OverviewChartNewsTraderScreen

CENTOGENE N.V. EO -,12/  NL0014040206  /

Frankfurt
2024-05-21  8:01:33 AM Chg. 0.0000 Volume Bid8:03:43 AM Ask8:03:43 AM High Low
0.3200EUR 0.00% 0
Turnover: 0.0000		 0.3200Bid Size: 5,000 0.3700Ask Size: 5,000 0.3200 0.3200
GlobeNewswire 05-15 CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
GlobeNewswire 05-14 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 05-10 CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
GlobeNewswire 04-02 CENTOGENE Receives Nasdaq Non-Compliance Notice
GlobeNewswire 03-19 CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing ...
GlobeNewswire 02-29 CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Huma...
GlobeNewswire 02-28 CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
GlobeNewswire 02-28 CENTOGENE Explores Strategic Alternatives
GlobeNewswire 02-01 FloQast and PAS Financial Advisory AG Announce Strategic Implementation Partnership to Drive Account...
GlobeNewswire 01-25 CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce R...
GlobeNewswire 01-24 CENTOGENE Receives French Research Tax Credit Accreditation
GlobeNewswire 01-23 CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Facto...
GlobeNewswire 01-18 CENTOGENE Announces Preliminary Full Year 2023 Revenue
GlobeNewswire 2023-12-19 CENTOGENE Announces Voting Results of Extraordinary General Meeting
GlobeNewswire 2023-12-13 CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment ...
GlobeNewswire 2023-11-28 CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Trans...
GlobeNewswire 2023-11-14 CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With N...
GlobeNewswire 2023-10-10 CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
GlobeNewswire 2023-09-11 CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 2023-09-07 CENTOGENE Reports First Half 2023 Financial Results
GlobeNewswire 2023-09-01 CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease ...
GlobeNewswire 2023-08-31 CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Hel...
GlobeNewswire 2022-03-24 CENTOGENE CEO Kim Stratton to Speak at BIO-Europe Spring® 2022 Conference
GlobeNewswire 2022-03-23 CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022
GlobeNewswire 2022-03-17 CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer